siRNA therapy lowers triglycerides in individuals with unusual problem
.STUDY HIGHLIGHT.19 September 2024.
Plozasiran lessened triglyceride degrees by 80% and also lowered the danger of pancreatitis in individuals along with chronic chylomicronemia, with or without a hereditary medical diagnosis.